Skip to main content
. Author manuscript; available in PMC: 2021 Aug 16.
Published in final edited form as: J Vasc Surg. 2019 May 28;69(6 Suppl):3S–125S.e40. doi: 10.1016/j.jvs.2019.02.016
Recommendation Grade Level of evidence Key references
8.1 Restrict use of therapeutic angiogenesis to CLTI patients who are enrolled in a registered clinical trial. 1 (Strong) B (Moderate) Abu Dabrh,4 2015
Peeters,113 2015
HHS Vulnerability Disclosure